According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...

We thank Yutaka Shimazu for his insightful comments. We agree that our positive findings1–4 highlight the urgent need for further work on biomarkers of neuronal damage and immune mechanisms in ...

Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.

The diversity of electronics components, including sensors, is constantly expanding.  In the health field, the sensors industry has produced in recent years multiple sensing devices used by do | ...

Brazilian researchers have developed a low-cost, portable biosensor that can quickly identify a protein whose altered levels are associated with psychiatric disorders, such as depression, ...

Vivan Therapeutics is a pioneer in cancer treatment innovation through its novel approach to personalized medicine. By using ...

At MIT’s Lincoln Laboratory, a new supercomputer has arrived. TX-GAIN, capable of two AI-exaflops, fuses more than six ...

A novel tool could reduce the time it takes to diagnose and classify acute leukemias from days to hours through DNA ...

Traditional chemotherapy drugs like 5-fluorouracil are poorly soluble, inefficient at reaching cancer cells, and cause severe side effects by damaging healthy tissue. In a promising advance for cancer ...

DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, "Proteomics Tools Report: Research and Clinical markets (2025-2030).

What we really do is we took the most constrained, complex, and costly medical imaging solution in radiology, and we ...